articleNature MedicineMar 13, 2024GREEN OA

Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results

SBStephen BagleyMLMeghan LogunJAJoseph A. FraiettaXWXin WangADArati Desai

Translational Therapeutics (United States) · University of Pennsylvania · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

320
total citations
FWCI
80.37
Percentile
100%
References
35
Citations per year

Authors

33

Topics & keywords

Topics
Keywords
  • Interim
  • Intrathecal
  • Medicine
  • Glioblastoma
  • Bivalent (engine)
  • Oncology
  • Pharmacology
  • Cancer research
UN Sustainable Development Goals
  • Zero hunger
No related works found for this paper.